9th Annual IBA World Life Sciences Conference

31 May - 2 Jun 2023

Session information

Plenary session seven - Criminal considerations for corporate counsel

Description

A life sciences company in the crosshairs of a government investigation faces wide variability in the penalties that can be brought against it and any responsible individuals within the company.  Learn from government and in-house lawyers across the globe about the risk of criminal liability for regulatory violations.  The panel will provide a comparison of the framework used in different countries for making prosecutorial decisions, and the compliance considerations that companies should consider minimising potential criminal exposure. 

Session / Workshop Chair(s)

Raj Pai Sidley Austin, Washington, District of Columbia, USA
Anne Walsh Hyman Phelps & McNamara PC, Washington, District of Columbia, USA; Vice Chair, Healthcare and Life Sciences Law Committee

Speakers

Martin Gantzhorn Gorrissen Federspiel, Copenhagen, Denmark; European Regional Forum Liaison Officer, Healthcare and Life Sciences Law Committee
Ross Goldstein US Department of Justice, Washington, District of Columbia, USA
Kathy Martin-Weis former Acting Director, US FDA, Office of Criminal Investigations, Washington, District of Columbia, USA